Medication info
Mepodine Tablet 500 mg (Metformin Hydrochloride)

Mepodine Tablet 500 mg (Metformin Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
100 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201802677 · Approved 2018.06.27 · Insurance code 678601070

Summary

Main use
Treatment of type 2 diabetes mellitus
Who uses it
Adults · Children
Adult dosage
The dose should be determined individually based on drug response and tolerability and should not exceed the recommended maximum daily dose. Treatment with this medicine must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 administrations daily with meals; the maximum daily dose is 2550mg. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess response to treatment with this medicine and identify the minimum effective dose. Measure blood glycated hemoglobin levels at approximately 3-month intervals. The treatment goal of this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled by diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment: This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡), who do not have other symptoms that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine must be discontinued immediately.
Children's dosage
Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes patients
  • overweight diabetes patients
View approved original text

This medication is used for patients with type 2 diabetes who have difficulty controlling blood sugar with diet and exercise alone. It can be used alone in overweight adult patients or in combination with other oral hypoglycemic agents or insulin. Additionally, it can be used as monotherapy or in combination with insulin for children over 10 years and adolescents in growth, helping with blood sugar control regardless of age. This medication effectively lowers blood sugar and plays a critical role in diabetes management, supporting the patient's healthy life.

Dosage and Administration

Adult dosage

The dose should be determined individually based on drug response and tolerability and should not exceed the recommended maximum daily dose. Treatment with this medicine must be initiated at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control. Administer 500mg 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When administering up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 administrations daily with meals; the maximum daily dose is 2550mg. When initiating treatment and adjusting the dose, measure fasting blood glucose to assess response to treatment with this medicine and identify the minimum effective dose. Measure blood glycated hemoglobin levels at approximately 3-month intervals. The treatment goal of this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled by diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment: This medicine may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡), who do not have other symptoms that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine must be discontinued immediately.

Children's dosage

Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is needed. It should not be administered to patients with moderate to severe renal impairment, acute heart failure, acute myocardial infarction, serious infections, or conditions affecting renal function. Additionally, the medication should be temporarily discontinued before and after examinations using iodine-based contrast agents, and can be resumed once renal function has normalized. It should also not be given to patients with hypersensitivity to this drug or to those with type 1 diabetes, diabetic ketoacidosis, severe infections, or severe traumatic systemic disorders. Discontinuation is required within 48 hours before surgery, and can be restarted only after confirming normal renal function post-surgery. Caution is also needed with malnutrition, weakness, liver dysfunction, lung dysfunction, and excessive alcohol consumption when using this medication. There is a risk of rare side effects such as lactic acidosis, with initial symptoms including fatigue, muscle pain, and shortness of breath; notify a healthcare professional immediately if abnormal symptoms occur. Gastrointestinal symptoms are common but mostly transient, and can be alleviated by gradually increasing the dose or taking it with food. Regular monitoring of renal function before and during treatment is necessary to reduce the risks of drug accumulation and lactic acidosis. Furthermore, the effectiveness of blood sugar control may change when taken with other hypoglycemic agents or certain medications, so consult with a physician. During pregnancy, as it can pass through the placenta, it should be used cautiously as needed, and should be avoided if there is a risk of fetal growth retardation. While breastfeeding, this medication is secreted in breast milk, so the need for treatment versus breastfeeding should be considered. Elderly patients are more likely to have reduced renal function, requiring dose adjustment and regular renal function tests. In case of overdose, the medication can be removed by hemodialysis, so immediate medical attention is necessary. It is important to avoid alcohol intake while taking this medication, and to regularly monitor blood glucose and blood tests to assess treatment effectiveness and possible side effects.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal bloating
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver function abnormalities
  • severe delayed hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air exposure and is best kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

100 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.